chr16-23480701-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015044.4(GGA2):c.950G>A(p.Arg317Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000345 in 1,612,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R317W) has been classified as Uncertain significance.
Frequency
Consequence
NM_015044.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GGA2 | NM_015044.4 | c.950G>A | p.Arg317Gln | missense_variant | 10/17 | ENST00000309859.8 | |
GGA2 | XM_047433801.1 | c.920G>A | p.Arg307Gln | missense_variant | 11/18 | ||
GGA2 | XM_047433802.1 | c.839G>A | p.Arg280Gln | missense_variant | 10/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GGA2 | ENST00000309859.8 | c.950G>A | p.Arg317Gln | missense_variant | 10/17 | 1 | NM_015044.4 | P1 | |
GGA2 | ENST00000567468.5 | c.624+6045G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000267 AC: 67AN: 251186Hom.: 0 AF XY: 0.000309 AC XY: 42AN XY: 135742
GnomAD4 exome AF: 0.000349 AC: 509AN: 1460546Hom.: 0 Cov.: 29 AF XY: 0.000362 AC XY: 263AN XY: 726616
GnomAD4 genome AF: 0.000315 AC: 48AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | The c.950G>A (p.R317Q) alteration is located in exon 10 (coding exon 10) of the GGA2 gene. This alteration results from a G to A substitution at nucleotide position 950, causing the arginine (R) at amino acid position 317 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at